Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis
Amy Guo,1 Michael Grabner,2 Swetha Rao Palli,2 Jessica Elder,1 Matthew Sidovar,1 Peter Aupperle,1 Stephen Krieger3 1Acorda Therapeutics Inc., Ardsley, New York, NY, USA; 2HealthCore Inc., Wilmington, DE, USA; 3Corinne Goldsmith Dickinson Center for MS, Icahn School of Medicine at Mount Sina...
Main Authors: | Guo A, Grabner M, Palli SR, Elder J, Sidovar M, Aupperle P, Krieger S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-patterns-and-health-care-resource-utilization-associated-wit-peer-reviewed-article-CEOR |
Similar Items
-
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis
by: Jara M, et al.
Published: (2014-12-01) -
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States
by: Jara M, et al.
Published: (2015-12-01) -
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment
by: Carrie Hersh, et al.
Published: (2012-07-01) -
Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
by: Hayes KC
Published: (2011-04-01) -
Dalfampridine: Review on its recent development for symptomatic improvement in patients with multiple sclerosis
by: Manav Malhotra, et al.
Published: (2016-11-01)